1. What Is the Single Cell RNA Sequencing Market?
The Single Cell RNA Sequencing Market covers droplet-based single-cell RNA-seq platforms, microwell single-cell capture systems, combinatorial barcoding split-pool methods, and multimodal CITE-seq tools. These technologies profile gene expression at the resolution of individual cells. Applications span tumor microenvironment characterization, cell type atlas construction, drug response heterogeneity mapping, and stem cell differentiation trajectory analysis. Market dynamics reflect Human Cell Atlas program investment, clinical tumor immune profiling scRNA-seq adoption, multimodal single-cell genomics platform expansion, and single-cell atlas-guided drug target discovery. Declining cost per cell and throughput improvements are continuously expanding scRNA-seq accessibility.
2. Single Cell RNA Sequencing Market Size & Forecast
3. Emerging Technologies
- Scalable single-cell combinatorial barcoding methods processing millions of cells per experiment are advancing. Growing adoption is driven by atlas-scale tissue profiling at costs lower than droplet microfluidics.
- Single-nucleus RNA-seq from frozen archived tissue enabling retrospective clinical sample profiling are advancing. Growing use is driven by the large repositories of banked frozen clinical specimens unavailable for fresh profiling.
- Spatial integration with scRNA-seq cell type deconvolution for tissue-resolved transcriptomics are advancing. Growing adoption is driven by tumor microenvironment spatial composition analysis in oncology programs.
- TCR and BCR V(D)J immune repertoire profiling paired with scRNA-seq are advancing in immune research. Growing use is driven by clonotype-expression linkage in autoimmunity and oncology immunology programs.
Similar technologies are also transforming adjacent markets. Learn more in our Spatial Transcriptomics Market.
4. Key Market Opportunity
The primary opportunity in the Single Cell RNA Sequencing Market is clinical tumor immune profiling. Human Cell Atlas-guided drug target discovery creates a pharmaceutical research platform revenue opportunity. Multimodal CITE-seq panel development creates a premium reagent and platform market. Asia Pacific scRNA-seq market growth in China and Japan creates geographic opportunity.
5. Top Companies in the Single Cell RNA Sequencing Market
The following organisations hold leading positions in the Single Cell RNA Sequencing Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- 10x Genomics (Chromium)
- Parse Biosciences
- Fluent BioSciences
- Scale Biosciences
- BD Biosciences (Rhapsody)
- Becton Dickinson
- Illumina (scRNA library kits)
- Pacific Biosciences
- Singular Genomics
- Curio Bioscience
6. Market Segmentation
The Single Cell RNA Sequencing Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Platform | Droplet-Based 10x ChromiumMicrowell CaptureSplit-Pool CombinatorialCITE-seq Multimodal |
| By Application | Tumor ProfilingCell AtlasDrug ResponseStem Cell DifferentiationImmunology |
| By End User | Academic ResearchPharmaceutical CompaniesCROsClinical Diagnostics |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Single Cell RNA Sequencing Market trajectory over the forecast period:
Human Cell Atlas Program Is Generating Reference Single-Cell Transcriptomic Maps Across Human Tissues.The HCA consortium aims to profile all cell types in the human body at single-cell resolution. Published HCA organ cell atlases provide reference gene expression profiles for 50+ tissue types. These atlases identify novel cell states, subtypes, and marker genes for biological research programs. HCA data is used by pharmaceutical companies to identify drug targets in disease-relevant cell types.
Clinical Tumor scRNA-seq Profiling Is Advancing Tumor Microenvironment-Based Patient Stratification.Single-cell profiling of tumors reveals immune cell composition, exhaustion states, and spatial organization. These profiles predict immunotherapy response and identify resistance mechanisms at single-cell resolution. Pharmaceutical oncology programs use scRNA-seq to stratify patients and select clinical biomarkers. Clinical scRNA-seq tumor profiling is advancing toward companion diagnostic applications in immuno-oncology.
Multimodal CITE-seq Simultaneously Measuring RNA and Protein in Single Cells Is Expanding.CITE-seq uses antibody-oligonucleotide conjugates to detect surface proteins alongside RNA in each cell. This dual measurement resolves cell types more precisely than RNA expression alone. BD Biosciences' ABSEQ and 10x Genomics' Feature Barcoding implement CITE-seq in commercial platforms. CITE-seq multimodal panels are advancing clinical immune cell profiling and biomarker discovery.
For related market intelligence, see the Rna Sequencing Market.
8. Segmental Analysis
By platform, the Droplet-Based 10x Chromium segment dominated the Single Cell RNA Sequencing Market in 2025. 10x Genomics holds the largest installed base across academic, pharmaceutical, and clinical scRNA-seq settings. The Multimodal CITE-seq segment is fastest-growing, driven by pharmaceutical immune cell phenotyping adoption.
9. Regional Analysis
Regional demand patterns across the Single Cell RNA Sequencing Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Single Cell RNA Sequencing Market in 2025 with a market share of 45.0%. The region leads single-cell genomics investment with 10x Genomics, Parse Biosciences, and Scale Bio based in the US. NIH-funded Human Cell Atlas contributions from US academic centers create substantial research demand. Moreover, US pharmaceutical companies lead scRNA-seq tumor microenvironment companion diagnostic development. In addition, North American academic centers drive CITE-seq multimodal single-cell technology innovation. Platform leadership and HCA investment sustain North American dominance through the forecast period.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR of 25.90% in the Single Cell RNA Sequencing Market through 2034. China's rapidly growing genomics research institutes and pharmaceutical programs are adopting scRNA-seq at scale. Japan's established single-cell biology research investment creates strong institutional procurement demand. Moreover, South Korea's national precision medicine programs drive single-cell genomics platform adoption. Research expansion and pharmaceutical growth position Asia Pacific for sustained scRNA-seq Market outperformance.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Single Cell RNA Sequencing Market was valued at USD 2.80 Bn in 2025 and is projected to reach USD 12.90 Bn by 2034, growing at a CAGR of 18.50% over the 2026–2034 forecast period.
The Single Cell RNA Sequencing Market is projected to grow at a CAGR of 18.50% from 2026 to 2034.
North America dominated the Single Cell RNA Sequencing Market in 2025 with a market share of 45.0%.
The leading companies in the Single Cell RNA Sequencing Market include 10x Genomics (Chromium), Parse Biosciences, Fluent BioSciences, Scale Biosciences, BD Biosciences (Rhapsody), Becton Dickinson, Illumina (scRNA library kits), Pacific Biosciences, Singular Genomics, Curio Bioscience.
Human cell atlas program is generating reference single-cell transcriptomic maps across human tissues.
By platform, the Droplet-Based 10x Chromium segment dominated the Single Cell RNA Sequencing Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.